A preliminary metabolomic analysis of older adults with and without depression.
about
Pharmacometabolomics of response to sertraline and to placebo in major depressive disorder - possible role for methoxyindole pathwayMetabolomics in early Alzheimer's disease: identification of altered plasma sphingolipidome using shotgun lipidomicsAdvantages and Pitfalls of Mass Spectrometry Based Metabolome Profiling in Systems BiologyDiscovery of biochemical biomarkers for aggression: A role for metabolomics in psychiatry.Proteomics, metabolomics, and protein interactomics in the characterization of the molecular features of major depressive disorder.Metabolic Profiling and Phenotyping of Central Nervous System Diseases: Metabolites Bring Insights into Brain Dysfunctions.The potential biomarker panels for identification of Major Depressive Disorder (MDD) patients with and without early life stress (ELS) by metabonomic analysis.Reduced level of glutamic acid decarboxylase-67 kDa in the prefrontal cortex in major depression.The diagnosis of depression: current and emerging methods.Stable isotope-resolved metabolomic analysis of lithium effects on glial-neuronal metabolism and interactionsNavigating the human metabolome for biomarker identification and design of pharmaceutical molecules.Altered interactions of tryptophan metabolites in first-episode neuroleptic-naive patients with schizophrenia.Biomarkers to predict antidepressant responseAn investigation of the antidepressant action of xiaoyaosan in rats using ultra performance liquid chromatography-mass spectrometry combined with metabonomics.Identifying individual differences of fluoxetine response in juvenile rhesus monkeys by metabolite profilingMetabolomic changes in autopsy-confirmed Alzheimer's diseasePharmacometabolomics: implications for clinical pharmacology and systems pharmacology.Metabolomic identification of biochemical changes induced by fluoxetine and imipramine in a chronic mild stress mouse model of depression.Plasma metabolomics reveals a potential panel of biomarkers for early diagnosis in acute coronary syndromeMacaques exhibit a naturally-occurring depression similar to humans.Opioid use affects antioxidant activity and purine metabolism: preliminary results.Proteomic analysis of serum from patients with major depressive disorder to compare their depressive and remission statuses.Pretreatment metabotype as a predictor of response to sertraline or placebo in depressed outpatients: a proof of concept.Metabolomics analysis reveals insights into biochemical mechanisms of mental stress-induced left ventricular dysfunction.NMR Metabolomics Analysis of Parkinson's DiseaseMetabolomic differences in heart failure patients with and without major depressionAltered Monoamine and Acylcarnitine Metabolites in HIV-Positive and HIV-Negative Subjects With Depression.Cerebrospinal fluid metabolome in mood disorders-remission state has a unique metabolic profileIdentification and validation of urinary metabolite biomarkers for major depressive disorderPharmacometabolomic mapping of early biochemical changes induced by sertraline and placebo.Neuropsychiatric Symptoms in Inborn Errors of Metabolism: Incorporation of Genomic and Metabolomic Analysis into Therapeutics and PreventionComparing metabolomic and pathologic biomarkers alone and in combination for discriminating Alzheimer's disease from normal cognitive aging.A pilot study of plasma metabolomic patterns from patients treated with ketamine for bipolar depression: evidence for a response-related difference in mitochondrial networks.Modulation of ion channels in clinical psychopharmacology: adults and younger people.Metabolomics: a novel approach to identify potential diagnostic biomarkers and pathogenesis in Alzheimer's disease.The search for peripheral disease markers in psychiatry by genomic and proteomic approaches.Metabolomic profiles of plasma, exhaled breath condensate, and saliva are correlated with potential for air toxics detection.Peripheral biomarkers of major depression and antidepressant treatment response: Current knowledge and future outlooks.Metabolite profiling of antidepressant drug action reveals novel drug targets beyond monoamine elevation.Study of plasma metabolic profiling and biomarkers of chronic unpredictable mild stress rats based on gas chromatography/mass spectrometry.
P2860
Q21559605-60C90CFA-9F6C-472F-B77C-134F6FAD8AAAQ21560953-8CBA0325-A8F3-4928-B54A-069233463F03Q26748877-A3D914D2-2E2D-4F7A-A1C4-E5404085C445Q30251871-09FBD594-CC63-481A-8C80-995A1D5F493CQ30801268-A48603B0-8DC2-4203-AFC3-2D3A5ECCD205Q30885784-1DF62002-369D-48F5-A21F-8134FAC44D3CQ33679513-25BDDDBB-BB87-4511-89E1-D75E0E00B1B5Q33802572-CFB4DB51-FFF1-464A-9B37-0F7D43F36DB0Q33887233-47674D3C-60C7-42B1-BDDF-0AA43CC5ED45Q33989596-E21ECB28-71A2-4C69-8798-FE4811BC3814Q34170091-76EF59CF-232E-45F7-B479-4F27C4F0A365Q34192207-2158B628-9FB5-4574-8362-438307C299E8Q34247513-DA2CA135-E85D-4A63-AAAF-6238DBA6BF2EQ34414219-6F0E93A0-FF35-4690-95FF-5ED7A422EA39Q34657982-D8CADB70-6B2B-4D8C-BD73-9A9DE6E89DABQ34700264-9FFAD7F3-02EB-4054-9983-0E07AB76A904Q35032056-4E0C237C-BB79-4B3C-B5CA-6DB676C46CB7Q35157192-878E0B7E-A677-4753-9C1C-77607941E9AFQ35187726-35366ADF-5334-4ADF-A153-99CDF45FF23DQ35188855-66DB0979-2269-4067-8C5E-BE6050937C52Q35247464-641A4A0C-15DF-4926-A95E-28B3C0A8D8ADQ35330622-C05885A1-06E7-4B2A-BEB1-30C4704E261BQ35596249-FD158BEB-529E-4523-BE16-CEFFFB58843DQ35606621-7B3B09F3-F76A-4FFD-A94A-97A9EDF47E63Q35734379-43A2CF60-6FAD-404B-B1F0-42ADD78CC114Q35757760-8E4FFD12-2D6C-458E-A6A6-45AE324EE14EQ36036109-FAF8E152-C998-4188-A3E6-6025C10DCA36Q36246448-E306C06A-17E4-46FE-8A57-D3C87DB585A3Q36508139-C687FF63-C630-4CB4-8C36-43B6FB2149E1Q36593835-53E550C1-D7CC-4043-AF83-ED43D80633FDQ36703069-AC7BB10F-F6C5-4A00-87CC-0B5C0BBB3743Q37485378-F8AB2C89-5187-4F91-ABD1-EE75656CAA4EQ37686306-DC7646ED-3E99-4911-BA30-F1C4D808BD70Q37960095-9ABCA868-FCA4-4843-AD6D-77CE8BF21A0AQ38051186-9AC0F044-BABA-4AE7-B6C9-46E58BF6CD18Q38089247-359036B4-3CDA-4A68-AB4F-C2D6AAE352C9Q38624968-5CC93980-7897-4E43-A804-7CB4B4CFDAC7Q38657429-E1FB883E-7728-4476-9DEE-35DCE2103CBEQ42026722-E4577D63-3132-4679-8C3B-3A7A48164843Q42810492-CA244BC5-A67A-4EBB-A36A-929BE90F674C
P2860
A preliminary metabolomic analysis of older adults with and without depression.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
A preliminary metabolomic analysis of older adults with and without depression.
@en
A preliminary metabolomic analysis of older adults with and without depression.
@nl
type
label
A preliminary metabolomic analysis of older adults with and without depression.
@en
A preliminary metabolomic analysis of older adults with and without depression.
@nl
prefLabel
A preliminary metabolomic analysis of older adults with and without depression.
@en
A preliminary metabolomic analysis of older adults with and without depression.
@nl
P2093
P2860
P356
P1476
A preliminary metabolomic analysis of older adults with and without depression
@en
P2093
David C Steffens
K Ranga R Krishnan
Lisa A Paige
P2860
P304
P356
10.1002/GPS.1690
P407
P577
2007-05-01T00:00:00Z